|
|
||||||||
Department of Nuclear Medicine and Diagnostic Imaging, and Department of Cardiovascular Surgery, Kyoto University Faculty of Medicine, Kyoto
Department of Nuclear Medicine, Hokkaido University, Sapporo, Japan
Correspondence: For correspondence or reprints contact: Masayuki Inubushi, MD, Department of Nuclear Medicine and Diagnostic Imaging, Kyoto University Faculty of Medicine, 54 Shogoin-Kawahara Sakyo, Kyoto 606-8507, Japan.
ABSTRACT
This study was designed to evaluate the methodological feasibility of 123I-labeled ß-methyl-p-iodophenyl-pentadecanoic acid (BMIPP)-gated SPECT to assess regional and global left ventricular (LV) function in comparison with 99mTc-sestamibi (methoxyisobutyl isonitrile [MIBI])-gated SPECT and first-pass radionuclide angiography (FPRNA). Methods: Forty-four patients with stable coronary artery disease underwent rest BMIPP-gated SPECT (111 Mbq, 60 s/step) and rest MIBI-gated SPECT (600 MBq, 40 s/step) within a week. From both gated SPECT studies, regional defect scores (DS), wall motion scores (WMS) and wall-thickening scores (WTS) were evaluated visually using 4-point scales for nine segments, and LV ejection fraction (EF) (%) was automatically calculated using Quantitative Gated SPECT (QGS) software. FPRNA was also performed on injection of MIBI. Results: Exact agreement between the two gated SPECT studies was 84.1% (
= 0.706, r = 0.907, P < 0.0001) in WMS and 87.1% (
= 0.662, r = 0.884, P < 0.0001) in WTS. LVEF obtained from BMIPP-gated SPECT linearly correlated with those from MIBI-gated SPECT (y = 0.27 + 0.944x, r = 0.948, SEE = 5.00, P < 0.0001) and FPRNA (y = 7.32 + 1.042x, r = 0.919, SEE = 6.19, P < 0.0001). Even in 21 patients with mismatch segments (BMIPP DS > MIBI DS), agreement was considered to be acceptable in WMS (81.5%,
= 0.707, r = 0.853, P < 0.0001) and in WTS (76.7%,
= 0.526, r = 0.754, P < 0.0001), and correlation in LVEF remained good between BMIPP-gated SPECT and MIBI-gated SPECT (y = 1.24 + 0.955x, r = 0.938, SEE = 6.25, P < 0.0001) or FPRNA (y = 6.03 + 1.024x, r = 0.913, SEE = 7.38, P < 0.0001). Conclusion: BMIPP-gated SPECT can evaluate regional and global LV function with the QGS software. Therefore, BMIPP-gated SPECT offers the opportunity for simultaneous assessment of myocardial free fatty acid utilization and LV function.
Key Words: gated SPECT 123I-ß-methyl-p-iodophenyl-pentadecanoic acid 99mTc-sestamibi first-pass radionuclide angiography left ventricular function
This article has been cited by other articles:
![]() |
V. Go, M. R. Bhatt, and R. C. Hendel The Diagnostic and Prognostic Value of ECG-Gated SPECT Myocardial Perfusion Imaging J. Nucl. Med., May 1, 2004; 45(5): 912 - 921. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nanasato, A. Ando, S. Isobe, M. Nonokawa, H. Hirayama, N. Tsuboi, T. Ito, M. Hirai, M. Yokota, and H. Saito Evaluation of Left Ventricular Function Using Electrocardiographically Gated Myocardial SPECT with 123I-Labeled Fatty Acid Analog J. Nucl. Med., December 1, 2001; 42(12): 1747 - 1756. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |